SEM - Select Medical GAAP EPS of $0.61 beats by $0.05 revenue of $1.67B in-line

August, 03 2023 05:32 PM Select Medical Holdings Corporation

2023-08-03 17:32:50 ET

Select Medical press release ( NYSE: SEM ): Q2 GAAP EPS of $0.61 beats by $0.05 .
Revenue of $1.67B (+5.7% Y/Y) in-line.
Select Medical expects consolidated revenue to be in the range of $6.55 billion to $6.7 billion for the full year of 2023, vs. consensus of $6.59B, Adjusted EBITDA to be in the range of $795.0 million to $825.0 million, and fully diluted earnings per share to be in the range of $1.77 to $1.94.
Select Medical expects adjusted earnings per share to be in the range of $1.86 to $2.03, vs. consensus of $1.92.
Shares -2% AH.

For further details see:

Company Name:	Select Medical Holdings Corporation
Stock Symbol:	SEM
Market:	NYSE
Website:	selectmedicalholdings.com